The following is a summary of “Effectiveness of recombinant follicle-stimulating hormone treatment in patients with ...

Following the success of Humulin, recombinant DNA technology was quickly adopted to replace older methods of producing medical products from human growth hormone to vaccines. Although scientists have ...

Given the early promise of transcriptomics, research using an ‘omics’-based approach involving genomics, transcriptomics, proteomics and metabolomics should be intensified in order to achieve improved ...

About Growject ® Growject ® is an injectable preparation containing recombinant human growth hormone, first launched in Japan by JCR in 1995. The dosage is administered subcutaneously 6–7 ...

Whistleblower scientists to fight government firing Report calls for revamping of whistleblower law One of the drugs they opposed was Monsanto's recombinant bovine growth hormone (rBGH), meant to ...